Bass Blasts Sanctions Bid, Says Drug AIA Reviews Aid Public
The organization run by hedge fund manager Kyle Bass that has challenged many drug patents under the America Invents Act fired back Wednesday at Celgene Corp.'s request that it be sanctioned...To view the full article, register now.
Already a subscriber? Click here to view full article